Eisenlohr-Moul, T., Prinstein, M., Rubinow, D., Young, S., Walsh, E., Bowers, S., & Girdler, S. (2018). S104. Ovarian Steroid Withdrawal Underlies Perimenstrual Worsening of Suicidality: Evidence From a Crossover Steroid Stabilization Trial. In Biological Psychiatry (Vol. 83, pp. S387–S387). Elsevier BV. https://doi.org/10.1016/j.biopsych.2018.02.995

Eisenlohr-Moul, Tory, Mitchell Prinstein, David Rubinow, Steven Young, Erin Walsh, Savannah Bowers, and Susan Girdler. “S104. Ovarian Steroid Withdrawal Underlies Perimenstrual Worsening of Suicidality: Evidence From a Crossover Steroid Stabilization Trial.” In Biological Psychiatry, 83:S387–S387. Elsevier BV, 2018. https://doi.org/10.1016/j.biopsych.2018.02.995.

Eisenlohr-Moul T, Prinstein M, Rubinow D, Young S, Walsh E, Bowers S, et al. S104. Ovarian Steroid Withdrawal Underlies Perimenstrual Worsening of Suicidality: Evidence From a Crossover Steroid Stabilization Trial. In: Biological Psychiatry. Elsevier BV; 2018. p. S387–S387.

Eisenlohr-Moul, Tory, et al. “S104. Ovarian Steroid Withdrawal Underlies Perimenstrual Worsening of Suicidality: Evidence From a Crossover Steroid Stabilization Trial.” Biological Psychiatry, vol. 83, no. 9, Elsevier BV, 2018, pp. S387–S387. Crossref, doi:10.1016/j.biopsych.2018.02.995.

Eisenlohr-Moul T, Prinstein M, Rubinow D, Young S, Walsh E, Bowers S, Girdler S. S104. Ovarian Steroid Withdrawal Underlies Perimenstrual Worsening of Suicidality: Evidence From a Crossover Steroid Stabilization Trial. Biological Psychiatry. Elsevier BV; 2018. p. S387–S387.